Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
78,365,632
-
Total 13F shares
-
25,403,494
-
Share change
-
+3,244,329
-
Total reported value
-
$630,501,046
-
Price per share
-
$24.85
-
Number of holders
-
74
-
Value change
-
+$87,474,116
-
Number of buys
-
59
-
Number of sells
-
16
Institutional Holders of Replimune Group, Inc. - COMMON STOCK (REPL) as of Q2 2020
As of 30 Jun 2020,
Replimune Group, Inc. - COMMON STOCK (REPL) was held by
74 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,403,494 shares.
The largest 10 holders included
Omega Fund Management, LLC, Redmile Group, LLC, BVF INC/IL, Bain Capital Life Sciences Investors, LLC, BlackRock Inc., FMR LLC, VICTORY CAPITAL MANAGEMENT INC, NORGES BANK, VANGUARD GROUP INC, and EMERALD ADVISERS, LLC.
This page lists
74
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.